Form 40-F/A - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]: [Amend]
SEC Accession No. 0001104659-22-047891
Filing Date
2022-04-20
Accepted
2022-04-20 16:49:24
Documents
87
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 40F/A crdl-20211231x40fa.htm   iXBRL 40-F/A 204940
2 EXHIBIT 99.2 crdl-20211231xex99d2.htm   iXBRL EX-99.2 1291616
8 GRAPHIC crdl-20211231x40fa001.jpg GRAPHIC 4035
9 GRAPHIC crdl-20211231xex99d2001.jpg GRAPHIC 30320
10 GRAPHIC crdl-20211231xex99d2005.jpg GRAPHIC 2782
11 GRAPHIC crdl-20211231xex99d2006.gif GRAPHIC 1630
  Complete submission text file 0001104659-22-047891.txt   7960246

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA crdl-20211231.xsd EX-101.SCH 80708
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crdl-20211231_cal.xml EX-101.CAL 33683
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crdl-20211231_def.xml EX-101.DEF 187867
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE crdl-20211231_lab.xml EX-101.LAB 504662
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crdl-20211231_pre.xml EX-101.PRE 384534
81 EXTRACTED XBRL INSTANCE DOCUMENT crdl-20211231x40fa_htm.xml XML 1768462
Mailing Address 602-2265 UPPER MIDDLE ROAD EAST OAKVILLE A6 L6H 0G5
Business Address 602-2265 UPPER MIDDLE ROAD EAST OAKVILLE A6 L6H 0G5 289-910-0850
Cardiol Therapeutics Inc. (Filer) CIK: 0001702123 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 40-F/A | Act: 34 | File No.: 001-40712 | Film No.: 22838682
SIC: 2836 Biological Products, (No Diagnostic Substances)